Salmonella typhimurium X4064, an attenuated Acya Acrp mutant of S. typhimurium , was used as a carrier for the plasmid pBA31-R7. This plasmid codes for the expression of a 31-kilodalton (kDa) protein from Brucella abortus (BCSP31). Recombinant S. typhimurium X4064(pBA31-R7) expressed BCSP31 in vitro as shown by Western blot (immunoblot) analysis. The plasmid was stable in vitro and in vivo and did not affect the ability of the mutant to invade and colonize the small intestine, mesenteric lymph nodes, liver, or spleen of BALB/cByJ mice. Animals orally immunized with S. typhimurium X4064(pBA31-R7) developed serum and intestinal antibody responses to the B. abortus 31-kDa protein and to salmonella endotoxin as measured by enzyme-linked immunosorbent assay. Mice orally immunized with S. typhimurium X4064pBA31-R7 did not develop a delayed-type hypersensitivity following a footpad injection with recombinant BCSP31. Antigenspecific blastogenic data also support these in vivo results. All data indicate that this route of antigen delivery is effective for stimulating antibody-mediated immunity but that the B. abortus 31-kDa protein is a poor immunogen for inducing a cell-mediated immune response in BALB/cByJ mice.
The majority of infectious agents which affect man and animals gain access to the host through a mucosal surface. Many of these pathogens are invasive, whereas others produce disease only at mucosal membranes (27) . An effective oral vaccine may need to target specific tissues and induce antibody or cell-mediated immunity. Currently, the majority of effective vaccines are administered parenterally, with the exception of a few live viral vaccines. Much of the difficulty in developing protocols for oral immunization has involved the delivery of sufficient antigen to effectively immunize the host without development of oral tolerance (24) . Since Salmonella typhimurium naturally invades and persists in gut-associated lymphoid tissue (4) , this organism delivers foreign antigen directly to the mucosal surface (7, 21, 22, 32) and stimulates secretory, humoral, and cellular immune responses (3, 7, 26) . With the use of recombinant DNA technology, the potential exists to effectively combine antigens within a single microorganism and to produce a vaccine for several different diseases simultaneously. This strategy is particularly attractive for the development of vaccines against enteric pathogens.
The present study examines the capabilities of an attenuated strain of S. typhimurium X4064 (Acya Acrp) to serve as a vehicle for delivery of a cloned antigen to the murine immune system. This strain has retained its ability to colonize and invade murine Peyer's patches and has been shown to induce protection against a lethal challenge of parent strain S. typhimurium SR-11 (9) . Mayfield et al. (23) recently cloned the gene for a Brucella abortus 31-kilodalton (kDa) protein (BCSP31) into Escherichia coli K-12 . As a marker antigen, the plasmid (pBA31-R7) expressing BCSP31 in E. coli K-12 was transduced into S. typhimurium X4064. The efficacy of S. typhimurium X4064(pBA31-R7) to colonize the murine gut-associated lymphoid tissue, liver, and spleen was * Corresponding author.
correlated with the induction of mucosal and systemic immunity to the heterologous BCSP31 marker antigen.
MATERIALS AND METHODS
Bacterial strains and plasmid. pBA31-R7, containing a 4.2-kilobase EcoRI fragment coding for BCSP31 (a 31-kDa Brucella protein), was propagated in E. coli HB101. S. typhimurium SL5283 (a restriction-negative, modificationpositive strain) was used as an intermediate transformation recipient of the plasmid DNA. An avirulent S. typhimurium SR-11 double mutant (Acya Acrp) X4064 (kindly provided by R. Curtiss III, Washington University, St. Louis, Mo.) was used for delivery of antigen in vivo. A P22 (HT, int-) transducing phage lysate was routinely produced from cultures of S. typhimurium X3000 (kindly provided by R. Curtiss III).
Genetic transformation and transduction. Because of restriction barriers, it was necessary to first transform pBA31-R7 into a restriction-negative, modification-positive rough salmonella strain (SL5283) (kindly provided by R. W. Griffith, Iowa State University, Ames, Iowa). This was accomplished by using the procedure of Lederberg and Cohen (18) with DNA isolated by using the method of Birnboim and Doly (1) and purified over a cesium chloride gradient (20) . The presence of the plasmid was confirmed by using a rapid screening technique (29) , and then the plasmid was transduced to S. typhimurium X4064 (Acya Acrp) by using P22 (HT, int-) as previously described (10) . Transductants were screened for expression of BCSP31 as described below.
Electrophoresis and immunoblot analysis. Horizontal gel electrophoresis of DNA was performed on 0.75% agarose slab gels in 89 mM Tris, 89 mM boric acid, and 2.5 mM EDTA (TBE buffer). HindIll-digested bacteriophage A DNA fragments were used as molecular weight standards. Restriction endonucleases were purchased from Bethesda Research Laboratories, Inc., Gaithersburg, Md. Vertical discontinuous polyacrylamide gel electrophoresis containing sodium dodecyl sulfate was performed with a 4% stacking gel over a 12.5% separating gel by the technique of Laemmli (17) . To detect protein separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, gels were stained with Coomassie blue (R250) by the method of Fairbanks et al. (13) .
To detect BCSP31 in S. typhimurium X4064(pBA31-R7), proteins from sodium dodecyl sulfate-polyacrylamide gels were electrophoretically transferred to nitrocellulose (Schleicher & Schuell, Inc., Keene, N.H.) by using a modification of the procedure described by Towbin et al. (33) . Membranes were treated with either rabbit anti-B. abortus strain 19 whole cell lysate sera or various sera from mice immunized with either purified BCSP31 or S. typhimurium X4064(pBA31-R7). Immunoblots were then incubated with either horseradish peroxidase or alkaline phosphatase-conjugated goat anti-mouse immunoglobulin (Fisher Scientific Co., Orangeburg, N.Y.). Conjugated antibodies were visualized with either TMB membrane peroxidase substrate (Kirkegaard and Perry, Gaithersburg, Md.) or with a substrate solution of 1 mg of naphthol AS-MX phosphate per ml and 2 mg of Fast Red TR salt per ml (Sigma Chemical Co., St. Louis, Mo.) as previously described (31) .
Antigen preparations. Purified BCSP31 was obtained from E. coli by using a modified procedure of Bricker et al. (2) and was designated rBCSP31. E. coli was grown in 2 liters of Luria-Bertani (LB) broth (20) containing ampicillin (100 ,ug/ml) for 36 h with shaking (260 rpm at 37°C). Cultures were centrifuged (8, 000 x g for 15 min), supernatants were discarded, and the pellets were weighed. The pellets were suspended in 2 ml of extraction buffer (10 mM phosphate buffer [pH 7.5] containing 0.1% Triton X-100) per g of packed cells and incubated at 37°C overnight with shaking (260 rpm). The cell suspension was transferred to glass Corex tubes and centrifuged (8,000 x g for 15 min), and the pellet was washed once with extraction buffer. Pooled supernatants were preserved by the addition of 0.01% Merthiolate, incubated for 1 h at room temperature, and dialyzed extensively against 10 mM Tris-5 mM NaCl (pH 7.5). The dialysate was then loaded onto a DEAE Sepharose CL6B column (Pharmacia LKB Biotechnology, Inc., Piscataway, N.J.) (bed volume, 280 ml) equilibrated in 10 mM Tris-5 mM NaCl (pH 7.5) (column buffer). After washing the column with 1.5 bed volumes of column buffer, selective elution of bound material was achieved with an NaCl gradient (5 (9, 12) . against TEAN buffer (4°C), and stored at -20°C until assayed by enzyme-linked immunosorbent assay (ELISA) for the presence of antibody to either the recombinant BCSP31 or to S. typhimurium X4064 endotoxin.
ELISA. All antibody titers were determined by ELISA by use of 96-well Immulon 1 microtiter plates (Dynatech, Chantilly, Va.) incubated overnight at 4°C with 2 pug of either rBCSP31 or S. typhimurium X4064 endotoxin diluted in 0.01 M PBS (pH 7.2). All sera were diluted 1/10 with saline containing 0.05% Tween-20 (TS); intestinal homogenates and saliva were used undiluted. Total immunoglobulin, immunoglobulin G (IgG), IgM, or IgA were determined by using alkaline phosphatase-conjugated goat anti-mouse antibodies to immunoglobulin (Fisher), IgG (gamma-chain specific), IgM (mu-chain specific), and IgA (alpha-chain specific) (Kirkegaard and Perry) at a 1/2,000 dilution in TS. Enzyme-substrate reactions were initiated by the addition of no. 104 phosphatase substrate (Sigma). Absorbance was measured at 405 nm, and the results were expressed as the mean plus or minus standard error of the mean of triplicate samples.
Delayed 
RESULTS
Construction of a recombinant S. typhimurium X4064 BCSP31 expression vector. Construction of the pBA31-R7 plasmid containing the gene for the production of BCSP31, a B. abortus cell surface protein, has already been reported (23) . Cesium chloride-purified pBA31-R7 was transformed into a restriction-negative, modification-positive intermediate host S. typhimurium SL 5283 prior to transduction into S.
typhimurium X4064 by using P22 bacteriophage (HT, int-). The presence of the plasmid in S. typhimurium X4064 was confirmed by plasmid analysis of cell lysates (Fig. 1) . 2 and 70 days post-oral immunization of mice were shown to contain pBA31-R7 by restriction digest mapping (Fig. 3) . Colonies recovered 70 days postinoculation were shown to express cloned BCSP31 by Western blot analysis (Fig. 1) .
Colonization of mice with recombinant S. typhimurium X4064. The insertion of the plasmid and expression of rBCSP31 protein in S. typhimurium X4064(pBA31-R7) did not affect colonization characteristics of the strain (data not shown). S. typhimurium X4064tpBA31-R7) colonization of the small intestine and mesenteric lymph nodes occurred rapidly within the first week after oral immunization, with peak colonization between days 7 and 10 (1 x 104 and 2.7 >K 104 cells per g of tissue, respectively) (Fig. 4) . Colonization of the spleen and liver occurred more gradually and at much lower cell numbers (3 x i and 1 x 1 cells per g of tissue, respectively). Peak colonization of both the spleen and the liver occurred at day 14 postinoculation (Fig. 4) . By day 21 (Fig.  7) . Under the given conditions, the intestinal IgA response to endotoxin was much stronger than the IgA response to rBCSP31, whereas the intestinal IgG response to each antigen was more nearly equal. A second oral dose of S. typhimurium X4064(pBA31-R7) ( 
DISCUSSION
The pBA31-R7 plasmid containing the gene for B. abortus 31-kDa protein (BCSP31) was transduced into S. typhimurium X4064 (Acya Acrp). The plasmid was found to be stable in both S. typhimurium SL5283 and X4064. S. typhimurium isolated from tissue homogenates of BALB/cByJ mice were still capable of in vitro expression of the cloned 31-kDa periplasmic protein (rBCSP31).
Colonization studies determined that between 7 and 14 days postinfection, S. typhimurium X4064(pBA31-R7) effectively invades and colonizes the small intestine, mesenteric lymph nodes, liver, and spleen. The progression of events after infection is in agreement with that noted by Carter and Collins (4) when mice were orally fed S. typhimurium. Except for a few resident salmonella, the majority of S. typhimurium X4064(pBA31-R7) cells were cleared by day 21. However, recombinant S. typhimurium X4064(pBA31-R7) has been isolated from the small intestines and spleens of infected mice 10 weeks post-primary oral immunization.
Oral delivery of rBCSP31 in an inherently invasive enteric bacteria, such as S. typhimurium, was an effective method for stimulation of humoral immunity. The strong humoral antibody response of orally infected mice against the rBCSP31 protein was equivalent to titers produced by mice parenterally immunized with rBCSP31 in FIA. In mice orally immunized with S. typhimurium X4064(pBA31-R7), serum immunoglobulin to rBCSP31 and salmonella endotoxin peaked at day 35 (Fig. 5) . Antigen-specific IgG was largely responsible for the increase in titer, although a small serum IgA response to rBCSP31 and endotoxin occurred on days 2 and 25, respectively (data not shown). Interestingly, the oral route of inoculation did not elicit a detectable serum IgM response to either the rBCSP31 or salmonella endotoxin.
The oral route of infection with live recombinant bacteria was also intended to stimulate a localized secretory antibody response to rBCSP31. Intestinal homogenates contained high-titer IgA directed against S. typhimurium X4064 endotoxin and a low-titer IgA response to rBCSP31. Each antigen also stimulated a low-level IgG response. In both cases, no IgM titers were apparent (Fig. 7) . Secretory responses to rBCSP31 and S. typhimurium X4064 endotoxin showed peak IgA titers at days 23 tively. In mice, 38% of the serum-derived, polymeric IgA has been shown to be transported via the liver into the bile (11) . This mechanism may have contributed to the level of antigen-specific IgA detected in the intestinal homogenates. However, it is unlikely that hepatobiliary transport of IgA was responsible for the low level of antigen-specific IgA detected in the serum. It has been shown in rats that as much as 90% of the serum-derived IgA is transported into the bile and that this mechanism contributes to the low level of serum IgA detected in rats (11) . To enhance mucosal immunity, Keren et al. (15) (8, 14) . Data supporting transport of serum polymeric IgA into glandular secretions other than the hepatobiliary system provide conflicting results. For example, serum IgA has been detected in saliva, colostrum, and milk samples, but its presence may vary from species to species depending on the availability of secretory component (30) . Antigen-specific IgA has been detected in murine saliva (5, 8, 14 X4064(pBA31-R7) given on day 14 or 21 post primary immunization. This lack of responsiveness may be due to IgA bound to the cell surface causing interference with intestinal absorption and invasion (27) . Others have proposed that the induction of regulatory T cells following oral immunization causes suppression (24, 34) of a local anamnestic response.
Even though S. typhimurium X4064(pBA31-R7) proved to be highly invasive, this alone was insufficient for production of an all-encompassing immune response to rBCSP31 (i.e., cell-mediated, humoral, and secretory responses). However, results indicated that the vector itself was adequately presented to the host immune system and elicited a cellular immune response. In both the DTH and blastogenesis assays, a cell-mediated response was elicited by primary s.c.
immunization with an S. typhimurium X4064(pBA31-R7) whole-cell sonic extract. It has been shown that S. typhimurium X4064 provided good protective immunity against virulent S. typhimurium infections (9) 
